Empty agenda sees UK CSD (Committee on the Safety of Devices) postpone meeting:
This article was originally published in Clinica
One of the most influential UK government bodies on medical devices, the Committee on the Safety of Devices, has postponed its meeting scheduled for November 21 since there were no urgent items on the agenda. The CSD is scheduled to meet every four months. Chairman John Williams decided that as there were no new items for consideration and the number of projects initiated at the last meeting would not be completed nor require input from the CSD until March, that it would be best to postpone the meeting. The next date is scheduled for March 20 2003, with the following meeting being rescheduled from July 17 to June 19 to avoid the holiday period.
You may also be interested in...
A patent-litigation settlement that Teva has reached with Ironwood and Allergan over Linzess will allow the Israeli firm to enter the US market with the linaclotide-based constipation treatment ahead of major rivals Mylan, Sandoz, Sun Pharma and Aurobindo.
Following Aspen’s admission last year that it was party to an illegal, anti-competitive agreement on fludrocortisone, Tiofarma has now also conceded to the UK’s Competition and Markets Authority that it took part in the deal.